| Mr Brian Richard Trudeau, PT | |
|
211 E Logan St, Suite 101, Caldwell, ID 83605-4882 | |
| (208) 454-9839 | |
| Not Available |
| Full Name | Mr Brian Richard Trudeau |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 211 E Logan St, Caldwell, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235207937 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 669 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Brian Richard Trudeau, PT 11581 W Creekrapids Dr, Star, ID 83669-5729 Ph: (208) 286-7292 | Mr Brian Richard Trudeau, PT 211 E Logan St, Suite 101, Caldwell, ID 83605-4882 Ph: (208) 454-9839 |
News Archive
In this conference, world renowned scholars and researchers from neuroscience, psychology, philosophy and ethics will discuss the neurophysiological and psychological basis of human subjective experience, the phenomenological and spiritual characteristics of these domains, and how these may interact in the process of practical reasoning and moral decision making.
A new book edited by researchers at Worcester Polytechnic Institute and the Stony Brook University School of Medicine provides a comprehensive look at the science and application of cellular therapies aimed at the leading cause of death--heart disease.
Tensha Therapeutics announced today that it has raised $15 million in a Series A financing to advance the development of small molecule bromodomain inhibitors for the treatment of cancer and other conditions by regulating the transcription of disease-associated genes.
Tethys Bioscience, Inc., a privately held company, announced today that the United States Patent and Trademark Office has granted the Company US Patent 7,723,050. The patent is directed to the company's groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition.
Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.
› Verified 3 days ago
Dr. Brian W Lee, DPT, OCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-454-0505 Fax: 208-454-0559 | |
Mr. Sean R Weatherston, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 211 E Logan St, Suite 101, Caldwell, ID 83605 Phone: 208-454-9839 Fax: 208-454-0727 | |
Mr. Mark W Wisenor, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3720 S Indiana Ave, Caldwell, ID 83605 Phone: 208-459-6041 Fax: 208-459-0346 | |
Travis William Palmer, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 211 E Logan St, Suite 101, Caldwell, ID 83605 Phone: 208-454-9839 Fax: 208-454-0727 | |
Breann Faye Fox, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 E Pine St, Caldwell, ID 83605 Phone: 208-454-5142 Fax: 208-454-5148 | |
Sandra S Schnell, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-454-0505 Fax: 208-454-0559 |